Accretion Pharmaceuticals IPO Details
| IPO Open Date: | May 14, 2025 |
| IPO Close Date: | May 16, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹96 to ₹101 Per Share |
| Issue Size: | Approx ₹29.75 Crores |
| Fresh Issue: | Approx ₹29.75 Crores |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Accretion Pharmaceuticals IPO Market Lot
The Accretion Pharmaceuticals IPO minimum market lot is 1200 shares with ₹1,21,200 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1200 | ₹1,21,200 |
| Retail Maximum | 1 | 1200 | ₹1,21,200 |
| S-HNI Minimum | 2 | 2,400 | ₹2,42,400 |
Accretion Pharmaceuticals IPO Dates
The Accretion Pharmaceuticals IPO date is May 14 and the close date is May 16. The Accretion Pharmaceuticals IPO allotment will be finalized on May 19 and the IPO listing on May 21.
| IPO Open Date: | May 14, 2025 |
| IPO Close Date: | May 16, 2025 |
| Basis of Allotment: | May 19, 2025 |
| Refunds: | May 20, 2025 |
| Credit to Demat Account: | May 20, 2025 |
| IPO Listing Date: | May 21, 2025 |
Promoters of Accretion Pharmaceuticals IPO
The promoters of the company are Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati.
About Accretion Pharmaceuticals IPO
Accretion Pharmaceuticals Limited, established in 2012, is one of the leading pharmaceutical companies involved in the manufacturing and marketing of Tablets, Capsules, and other healthcare products. Other than manufacturing its products for sale, the company also manufactures various pharmaceutical products for other brands through license agreements or contract manufacturing. The company has achieved various certifications, showcasing its commitment to the quality and environmental standards. The manufacturing facility is situated in Ahemdabad, Sanand, Gujarat. Accretion Pharmaceutical has established its presence in more than 20 countries by expanding its business in various regions such as Africa, Southeast Asia, and the Middle East. The company comprises a total of 83 employees, including 4 Executive Directors, as of January 2025.
Accretion Pharmaceuticals IPO Company Financial Report
The company reported revenue of ₹33.94 crores in 2024 against ₹29.53 crore in 2023. The company reported profit of ₹3.88 crores in 2024 against profit of ₹0.10 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹22.58 | ₹783.90 | ₹0.08 | ₹17.74 |
| 2023 | ₹29.53 | ₹1472.25 | ₹0.10 | ₹20.58 |
| 2024 | ₹33.94 | ₹2883.26 | ₹3.88 | ₹27.05 |
| July 2024 | ₹11.89 | ₹1423.72 | ₹1.57 | ₹29.34 |
Accretion Pharmaceuticals IPO Valuation – FY2024
Check Accretion Pharmaceuticals IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 72.80% |
| ROCE: | 36.73% |
| EBITDA Margin: | 23.06% |
| PAT Margin: | 11.51% |
| Debt to equity ratio: | 2.52 |
| Earning Per Share (EPS): | ₹9.69 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 72.47% |
| Net Asset Value (NAV): | ₹- |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Sakar Healthcare Limited | 5.64 | 65.30 | 4.45% | 120.65 | – Cr. |
| Lincoln Pharmaceuticals Limited | 46.58 | 12.58 | 15.74% | 295.98 | – Cr. |
| Sotac Pharmaceuticals Limited | 5.24 | 23.09 | 11.91% | 43.69 | – Cr. |
Objects of the Issue
- Capital expenditure towards purchase of new equipment/ machineries, etc.
- Capital expenditure towards upgradation of existing manufacturing facility
- Repayment/prepayme nt of certain borrowings availed by the Company
- Funding working capital requirements
- General Corporate Purpose
Accretion Pharmaceuticals IPO Review
- IPO Watch – May Apply
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
Accretion Pharmaceuticals IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Managers aka Merchant Bankers
- Jawa Capital Services Private Limited
Company Address
Accretion Pharmaceuticals Limited
29 Xcelon Ind Park 1,
B/h, Intas Pharmaceuticals, Vasna Chacharvad
Sanand,
Phone: +91-97148 82929
Email: [email protected]
Website: https://accretionpharma.com/
Accretion Pharmaceuticals IPO FAQs
What is Accretion Pharmaceuticals IPO?
When Accretion Pharmaceuticals IPO will open for subscription?
What is Accretion Pharmaceuticals IPO Investors Portion?
How to Apply the Accretion Pharmaceuticals IPO?
What is Accretion Pharmaceuticals IPO Issue Size?
What is Accretion Pharmaceuticals IPO Price Band?
What is Accretion Pharmaceuticals IPO Lot Size?
What is the Accretion Pharmaceuticals IPO Allotment Date?
What is the Accretion Pharmaceuticals IPO Listing Date?
Note: The Accretion Pharmaceuticals IPO price band and date are officially announced. The (Accretion Pharmaceuticals IPO grey market premium) will be added to the IPO GMP page as it will start).
